Fig. 1: CONSORT flow diagram. | Nature Medicine

Fig. 1: CONSORT flow diagram.

From: Recombinant monoclonal antibody siltartoxatug versus plasma-derived human tetanus immunoglobulin for tetanus: a randomized, double-blind, active-controlled, phase 3 trial

Fig. 1: CONSORT flow diagram.The alternative text for this image may have been generated using AI.

The full analysis set included all randomized participants who received the study drug. The safety set included all treated participants with at least one postadministration safety evaluation. The full analysis set was used for efficacy analysis. The safety set was used for safety analysis.

Back to article page